| Sign In to gain access to subscriptions and/or personal tools. |
Modulation of Doxorubicin-Induced Genotoxicity by Aegle marmelos in Mouse Bone Marrow: A Micronucleus StudyDepartment of Radiobiology, Kasturba Medical College, Manipal, India; Department of Human Nutrition, College of Applied Health Sciences, 1919 West Taylor Street, MC 517, University of Illinois at Chicago, Chicago, IL 60612. ponemone{at}uic.edu
Department of Oral Medicine and Radiology, Manipal College of Dental Sciences, Manipal, India.
Department of Radiobiology, Kasturba Medical College, Manipal, India.
Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal, India.
Department of Radiobiology, Kasturba Medical College, Manipal, India. The effect of various concentrations of Aegle marmelos (AME) on the doxorubicin (DOX)-induced genotoxic effects in mice bone marrow was studied. Treatment of mice with different concentrations of DOX resulted in a dose-dependent elevation in the frequency of micronucleated polychromatic (MPCE) as well as normochromatic (MNCE) erythrocytes in mouse bone marrow. The frequencies of MPCE and MNCE increased with scoring time, and the greatest elevation for MPCE was observed at 48 hours post-DOX treatment, whereas a maximum increase in MNCE was observed at 72 hours post-DOX treatment. This increase in MPCE and MNCE was accompanied by a decline in the polychromatic erythrocytesnormochromatic erythrocytes (PCE/NCE) ratio, which showed a DOX-dose-dependent decline. Treatment of mice with 200, 250, 300, 350, and 400 mg/kg body weight of AME, orally once daily for 5 consecutive days before DOX treatment, significantly reduced the frequency of DOX-induced micronuclei accompanied by a significant elevation in the PCE/NCE ratio at all scoring times. The greatest protection against DOX-induced genotoxicity was observed at 350 mg/kg AME. The protection against DOX-induced genotoxicity by AME may be due to inhibition of free radicals and increased antioxidant status.
Key Words: Aegle marmelos doxorubicin genotoxicity mice bone marrow micronucleus
Integrative Cancer Therapies, Vol. 6, No. 1,
42-53 (2007) | ||